Deutsche Bank
OTLK icon

Deutsche Bank’s Outlook Therapeutics OTLK Stock Holding History

Deutsche Bank’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,938
Closed -$4.7K – 3694
2025
Q2 		$4.7K Buy
2,938
+813
+38% +$1.3K ﹤0.01% 3530
2025
Q1 		$2.59K Buy
2,125
+1,419
+201% +$2.49K ﹤0.01% 3544
2024
Q4 		$1.33K Sell
706
-6,626
-90% -$27.3K ﹤0.01% 3571
2024
Q3 		$39.2K Hold
7,332
– – ﹤0.01% 3399
2024
Q2 		$54.1K Buy
7,332
+6,819
+1,329% +$54.7K ﹤0.01% 3311
2024
Q1 		$6.13K Sell
513
-1
-0.2% -$8 ﹤0.01% 3554
2023
Q4 		$4.01K Hold
514
– – ﹤0.01% 3577
2023
Q3 		$2.26K Sell
514
-2,662
-84% -$58.9K ﹤0.01% 3637
2023
Q2 		$111K Sell
3,176
-1,787
-36% -$48.7K ﹤0.01% 3226
2023
Q1 		$108K Buy
4,963
+2,405
+94% +$53.8K ﹤0.01% 3294
2022
Q4 		$55.3K Buy
2,558
+40
+2% +$870 ﹤0.01% 3536
2022
Q3 		$61K Sell
2,518
-396
-14% -$9.21K ﹤0.01% 3534
2022
Q2 		$60K Buy
2,914
+329
+13% +$9.46K ﹤0.01% 3707
2022
Q1 		$92K Sell
2,585
-505
-16% -$15.8K ﹤0.01% 3612
2021
Q4 		$84K Buy
3,090
+529
+21% +$18.9K ﹤0.01% 3776
2021
Q3 		$111K Sell
2,561
-39
-2% -$1.88K ﹤0.01% 3857
2021
Q2 		$129K Buy
+2,600
New +$121K ﹤0.01% 4031
2020
Q1 		– Sell
-1,285
Closed -$15K – 4680
2019
Q4 		$15K Buy
+1,285
New +$29.9K ﹤0.01% 4386
2019
Q3 		– Sell
-20
Closed – – 5163
2019
Q2 		$0 Sell
20
-538
-96% -$25.1K ﹤0.01% 5452
2019
Q1 		$82K Buy
+558
New +$78.8K ﹤0.01% 4372

Other funds holding OTLK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank's OTLK Position: Q3 2025 in Review

Deutsche Bank sold out of Outlook Therapeutics (OTLK) in Q3 2025, closing a stake of 2,938 shares — an estimated $4.7K sold.

Deutsche Bank first reported a position in OTLK in Q1 2019 and held it in 20 quarters. The position peaked at $129K in Q2 2021. 54 funds tracked by Wall St. Rank hold OTLK as of Q3 2025.

  • Deutsche Bank reported no remaining Outlook Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Deutsche Bank sold 2,938 Outlook Therapeutics shares in Q3 2025, an estimated $4.7K.
  • Deutsche Bank first reported a position in Outlook Therapeutics in Q1 2019 and held it in 20 quarters.
  • Deutsche Bank's Outlook Therapeutics position peaked at $129K in Q2 2021.
  • 54 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q3 2025.

Based on Deutsche Bank's 13F filing for Q3 2025, filed 13 Nov 2025.